Crystal structure identifies molecular arrangement of 3-cinnamoyl-2,6-dihydroxy-4-methoxy-5-methylbenzaldehyde, indicating its potential applications.
C 18 H 16 O 5 , monoclinic, P 2 1 / n (no. 14), a = 11.72975(12) Å, b = 11.37270(9) Å, c = 12.41488(14) Å, β = 111.3565(13)°, V = 1542.41(3) Å 3 , Z = 4, R gt ( F ) = 0.0387, wR ref ( F 2 ) = 0.0387, T = 273 K.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: